fda compounding semaglutide warning letters october 2025 Hims and Hers warns investors about potential liability for FDA-regulated compounded prescription drug ads – Partnership for Safe Medicines The FDA has announced that

Rybelsus Rybelsus (semaglutide) is an oral GLP-1 medicatoin and an alternative to Ozempic

Exenatide Adjunct to Nicotine Patch Facilitates Smoking Cessation and May Reduce Post-Cessation Weight Gain: A Pilot Randomized Controlled Trial

Prioritize protein and fiber

When your reconstituted retatrutide is at 5mg/mL and you want a 2mg dose: 2mg 5mg/mL = 0.4mL = 40 IU on the syringe Pull the plunger back until the black rubber tip aligns with the "40" mark When you're at 10mg/mL and want a 2mg dose: 2mg 10mg/mL = 0.2mL = 20 IU on the syringe Pull the plunger back until the black rubber tip aligns with the "20" mark Half-Unit Precision For small doses (0.5mg or 1mg), you'll be drawing very small volumes sometimes just 510 IU

In a statement at the time, Novo noted that the recent explosion of irresponsible and misleading advertising about compounded GLP-1 drugs puts patients safety at risk and we cannot stay silent. Lilly followed suit, launching a new campaign in February that urged consumers to be healthy skeptics when it comes to compounded drugs

BMJ (2014) 348:g2366